Skip Navigation

Spondylarthropathies

Citations 31-40 of 281 total displayed.

Past content (since Apr 2000):

CLINICAL
Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register
L. E. Kristensen, P. Geborek, and T. Saxne
Rheumatology 2009; 48: 243-245. [Abstract] [Full Text]  

CLINICAL
Health care utilization in patients with spondyloarthropathies
J. A. Singh and V. Strand
Rheumatology 2009; 48: 272-276. [Abstract] [Full Text]  

CLINICAL
Patients with ankylosing spondylitis have increased sick leave—a registry-based case–control study over 7 yrs
Britta Strömbeck, Lennart T. H. Jacobsson, Ann Bremander, Martin Englund, Anders Heide, Aleksandra Turkiewicz, and Ingemar F. Petersson
Rheumatology 2009; 48: 289-292. [Abstract] [Full Text]  

LETTERS TO THE EDITOR
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis
P. Pasquetti, G. Morozzi, and M. Galeazzi
Rheumatology 2009; 48: 315-316. [Extract] [Full Text]  

CASE REPORTS
Possible miliary tuberculosis during adalimumab therapy with negative {gamma}-IFN release assays
A. L. Endean, S. M. Barry, and S. A. Young-Min
Rheumatology 2009; 48: 319-320. [Extract] [Full Text]  

CLINICAL
Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis
Y.-Y. Leung, L. S. Tam, K. W. Lee, M. H. Leung, E. W. Kun, and E. K. Li
Rheumatology 2009; 48: 53-56. [Abstract] [Full Text]  

CLINICAL
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice
C. D. Poole, P. Conway, and C. J. Currie
Rheumatology 2009; 48: 78-82. [Abstract] [Full Text]  

EDITORIALS
What is the most important outcome parameter in ankylosing spondylitis?
J. Braun and J. Sieper
Rheumatology 2008; 47: 1738-1740. [Extract] [Full Text]  

BASIC SCIENCE
Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis
S. T. Choi, J. H. Kim, E.-J. Kang, S.-W. Lee, M.-C. Park, Y.-B. Park, and S.-K. Lee
Rheumatology 2008; 47: 1775-1779. [Abstract] [Full Text]  

BASIC SCIENCE
Lack of association between Tenascin-C gene and spondyloarthritis
E. Zinovieva, N. Lebrun, F. Letourneur, F.-X. Laurent, R. Said-Nahal, G. Chiocchia, and M. Breban
Rheumatology 2008; 47: 1655-1658. [Abstract] [Full Text] [ Supplementary Data ]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

* Collected Resources Home

* Related collections:
 Rheumatology
 Benign Joint Hypermobility Syndrome
 Crystal Arthritis
 Diagnostics and Imaging Procedures
 Education
 Experimental Arthritis
 Fibromyalgia
 Health Economics
 Historical Medicine
 Immunogenetics
 Myositis and Muscle Disease
 Osteoarthritis and Cartilage
 Osteoporosis and Metabolic Bone Disease
 Pharmacology
 Pregnancy and Rheumatic Diseases
 Psychology: Measurement and Management of Pain
 Rehabilitation
 Rheumatoid Arthritis
 Sjogren's Syndrome
 Soft Tissue Rheumatism
 Spinal Pain
 Spondylarthropathies
 Systemic Lupus Erythematosus and Autoimmunity
 Systemic Sclerosis
 Vasculitis